Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients

View ORCID ProfileFien HR De Winter, View ORCID ProfileAn Hotterbeekx, Manon Huizing, View ORCID ProfileAngelina Konnova, View ORCID ProfileErik Fransen, View ORCID ProfileBart’s Jongers, Ravi Kumar Jairam, View ORCID ProfileVincent Van averbeke, View ORCID ProfilePieter Moons, View ORCID ProfileElla Roelant, View ORCID ProfileDebbie Le Blon, View ORCID ProfileWim Vanden Berghe, View ORCID ProfileAnnelies Janssens, View ORCID ProfileWillem Lybaert, View ORCID ProfileLieselot Croes, View ORCID ProfileChristof Vulsteke, View ORCID ProfileSurbhi Malhotra-Kumar, View ORCID ProfileHerman Goossens, View ORCID ProfileZwi Berneman, View ORCID ProfileMarc Peeters, View ORCID ProfilePeter van Dam, View ORCID ProfileSamir Kumar-Singh
doi: https://doi.org/10.1101/2021.10.29.21265511
Fien HR De Winter
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fien HR De Winter
An Hotterbeekx
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for An Hotterbeekx
Manon Huizing
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
3Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelina Konnova
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Angelina Konnova
Erik Fransen
4StatUa, Center for Statistics, University of Antwerp, Antwerp, B-2000, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Erik Fransen
Bart’s Jongers
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bart’s Jongers
Ravi Kumar Jairam
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Van averbeke
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vincent Van averbeke
Pieter Moons
3Biobank, Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pieter Moons
Ella Roelant
4StatUa, Center for Statistics, University of Antwerp, Antwerp, B-2000, Belgium
6Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, B-2650, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ella Roelant
Debbie Le Blon
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Debbie Le Blon
Wim Vanden Berghe
8PPES Lab Protein Chemistry, Proteomics & Epigenetic Signaling, IPPON, Department Biomedical Sciences, University Antwerp, Universiteitsplein 1, Wilrijk B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Wim Vanden Berghe
Annelies Janssens
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Annelies Janssens
Willem Lybaert
9Department of Medical Oncology, AZ Nikolaas, Sint-Niklaas, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Willem Lybaert
Lieselot Croes
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
10Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lieselot Croes
Christof Vulsteke
6Clinical Trial Center (CTC), CRC Antwerp, Antwerp University Hospital, University of Antwerp, Edegem, B-2650, Belgium
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
10Integrated Cancer Center Ghent, Department of Medical Oncology, AZ Maria Middelares Ghent, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christof Vulsteke
Surbhi Malhotra-Kumar
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Surbhi Malhotra-Kumar
Herman Goossens
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Herman Goossens
Zwi Berneman
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Zwi Berneman
Marc Peeters
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marc Peeters
Peter van Dam
2Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Wilrijkstraat 10, Edegem, B-2650, Belgium
7Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter van Dam
Samir Kumar-Singh
1Molecular Pathology Group, Laboratory of Cell Biology & Histology, Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
5Laboratory of Medical Microbiology, Vaccine and Infectious disease Institute, University of Antwerp, Universiteitsplein 1, Wilrijk, B-2610, Belgium
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samir Kumar-Singh
  • For correspondence: samir.kumarsingh{at}uantwerpen.be
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Cytokines, chemokines and (angiogenic) growth factors (CCGs) have been shown to play an intricate role in the progression of both solid and haematological malignancies. Recent studies have shown that SARS-CoV-2 infection leads to worse outcome in cancer patients, especially in haematological malignancy patients. Here, we investigated how SARS-CoV-2 infection impacts the already altered CCG levels in solid or haematological malignancies, specifically whether there is a protective effect or rather a potentially higher risk for major COVID-19 complications in cancer patients due to elevated CCGs linked to cancer progression. Serially analysing immune responses with 55 CCGs in cancer patients under active treatment with or without SARS-CoV-2 infection, we first showed that cancer patients without SARS-CoV-2 infection (n=54) demonstrate elevated levels of 35 CCGs compared to the non-cancer, non-infected control group of health care workers (n=42). Of the 35 CCGs, 19 were common to both solid and haematological malignancy groups and comprised previously described cytokines such as IL-6, TNF-α, IL-1Ra, IL-17A, and VEGF, but also several less well described cytokines/chemokines such as Fractalkine, Tie-2, and T cell chemokine CTACK. Importantly, we show here that 7 CCGs are significantly altered in SARS-CoV-2 exposed cancer patients (n=52). Of these TNF-α, IFN-β, TSLP and sVCAM-1, identified to be elevated in haematological cancers, are also known tumour-promoting factors. Longitudinal analysis conducted over 3 months showed persistence of several tumour-promoting CCGs in SARS-CoV-2 exposed cancer patients. These data urge for increased vigilance for haematological malignancy patients as a part of long COVID follow-up.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The clinical study was funded by Kom Op Tegen Kanker grant (#000100470), a UZA Foundation grant (2020), and University of Antwerp Grants (#42839). The laboratory reagents were funded by GOA (s30729). FDH and AH are funded by COMBACTE (the Innovative Medicines Initiative Joint Undertaking under grant agreements COMBACT MAGNET and COMBACT CARE (no. 115523 and 115737) resources, which are composed of financial contribution from the European Union Seventh Framework Program (FP7/2007 2013) and EFPIA companies in kind contribution), AK by H2020-Orchestra, and BsJ and VVa by FWO (FWO SB151525 and FWO 1S93418N).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics Committee of the Antwerp University Hospital gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Shared senior authorship

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted October 29, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
Fien HR De Winter, An Hotterbeekx, Manon Huizing, Angelina Konnova, Erik Fransen, Bart’s Jongers, Ravi Kumar Jairam, Vincent Van averbeke, Pieter Moons, Ella Roelant, Debbie Le Blon, Wim Vanden Berghe, Annelies Janssens, Willem Lybaert, Lieselot Croes, Christof Vulsteke, Surbhi Malhotra-Kumar, Herman Goossens, Zwi Berneman, Marc Peeters, Peter van Dam, Samir Kumar-Singh
medRxiv 2021.10.29.21265511; doi: https://doi.org/10.1101/2021.10.29.21265511
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Blood cytokine analysis suggests that SARS-CoV-2 infection results in a sustained tumour promoting environment in cancer patients
Fien HR De Winter, An Hotterbeekx, Manon Huizing, Angelina Konnova, Erik Fransen, Bart’s Jongers, Ravi Kumar Jairam, Vincent Van averbeke, Pieter Moons, Ella Roelant, Debbie Le Blon, Wim Vanden Berghe, Annelies Janssens, Willem Lybaert, Lieselot Croes, Christof Vulsteke, Surbhi Malhotra-Kumar, Herman Goossens, Zwi Berneman, Marc Peeters, Peter van Dam, Samir Kumar-Singh
medRxiv 2021.10.29.21265511; doi: https://doi.org/10.1101/2021.10.29.21265511

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3285)
  • Dentistry and Oral Medicine (362)
  • Dermatology (276)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1168)
  • Epidemiology (13347)
  • Forensic Medicine (19)
  • Gastroenterology (898)
  • Genetic and Genomic Medicine (5139)
  • Geriatric Medicine (480)
  • Health Economics (781)
  • Health Informatics (3260)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1189)
  • Hematology (428)
  • HIV/AIDS (1015)
  • Infectious Diseases (except HIV/AIDS) (14617)
  • Intensive Care and Critical Care Medicine (912)
  • Medical Education (476)
  • Medical Ethics (126)
  • Nephrology (522)
  • Neurology (4911)
  • Nursing (262)
  • Nutrition (725)
  • Obstetrics and Gynecology (880)
  • Occupational and Environmental Health (795)
  • Oncology (2517)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (542)
  • Pediatrics (1299)
  • Pharmacology and Therapeutics (549)
  • Primary Care Research (555)
  • Psychiatry and Clinical Psychology (4198)
  • Public and Global Health (7489)
  • Radiology and Imaging (1703)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (479)
  • Sexual and Reproductive Health (496)
  • Sports Medicine (424)
  • Surgery (547)
  • Toxicology (72)
  • Transplantation (235)
  • Urology (203)